John Hussman's STOK Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 84,000 shares of Stoke Therapeutics, Inc. (STOK) worth $2.74 M, representing 0.59% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, John Hussman has initiated a new position in STOK, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 21,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Stoke Therapeutics (STOK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Stoke Therapeutics (STOK) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +21,000 | Add 33.33% | 84,000 | $32.56 |
| Q4 2025 | +63,000 | New Buy | 63,000 | $31.74 |
John Hussman's Stoke Therapeutics Investment FAQs
John Hussman first purchased Stoke Therapeutics, Inc. (STOK) in Q4 2025, acquiring 63,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Stoke Therapeutics, Inc. (STOK) for 2 quarters since Q4 2025.
John Hussman's largest addition to Stoke Therapeutics, Inc. (STOK) was in Q4 2025, adding 63,000 shares worth $2 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 84,000 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $2.74 M.
As of the Q1 2026 filing, Stoke Therapeutics, Inc. (STOK) represents approximately 0.59% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Stoke Therapeutics, Inc. (STOK) was 84,000 shares, as reported at the end of Q1 2026.